13D/G large-stake feed

Latest 13D/G Reports

Since 06 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G/A

ARMISTICE CAPITAL, LLC stake in Presidio Property Trust, Inc.

Holder CIK 0001601086

13G/A SQFT
CIK
0001601086
Issuer
Presidio Property Trust, Inc.
Security
SQFT
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5% / 75,718 shares
Filed
15 May 2026, 11:20:57 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in HCW Biologics Inc.

Holder CIK 0001601086

13G/A HCWB
CIK
0001601086
Issuer
HCW Biologics Inc.
Security
HCWB
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5% / 353,680 shares
Filed
15 May 2026, 11:20:34 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in GEOVAX LABS, INC.

Holder CIK 0001601086

13G/A GOVX
CIK
0001601086
Issuer
GeoVax Labs, Inc.
Security
GOVX
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
10% / 291,155 shares
Filed
15 May 2026, 11:19:44 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in Treace Medical Concepts, Inc.

Holder CIK 0001601086

13G/A TMCI
CIK
0001601086
Issuer
TREACE MEDICAL CONCEPTS, INC.
Security
TMCI
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
9.8% / 6,364,000 shares
Filed
15 May 2026, 11:19:26 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in GLUCOTRACK, INC.

Holder CIK 0001601086

13G/A GCTK
CIK
0001601086
Issuer
Glucotrack, Inc.
Security
GCTK
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5% / 102,115 shares
Filed
15 May 2026, 11:17:52 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

Caligan Partners LP stake in SAB Biotherapeutics, Inc.

Holder CIK 0001727492

13G SABS
CIK
0001727492
Issuer
SAB Biotherapeutics, Inc.
Security
SABS
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
10% / 7,967,207 shares
Filed
15 May 2026, 11:17:49 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
1,601-1,650 of 3,993
Per page
50
Current page
33

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

10%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

ARMISTICE CAPITAL, LLC

Presidio Property Trust, Inc. (SQFT)

Schedule 13G/A Ownership 5% Filing-backed
CIK
000117266126002155
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
5%
Filed
15 May 2026, 11:20:57 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for Presidio Property Trust, Inc. (SQFT). Reported class ownership: 5%. Ownership change: -5%. Share change: -53%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

HCW Biologics Inc. (HCWB)

Schedule 13G/A Ownership 5% Filing-backed
CIK
000117266126002154
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
5%
Filed
15 May 2026, 11:20:34 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for HCW Biologics Inc. (HCWB). Reported class ownership: 5%. Ownership change: -5%. Share change: -12%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

GEOVAX LABS, INC. (GOVX)

Schedule 13G/A Ownership 10% Filing-backed
CIK
000117266126002153
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
10%
Filed
15 May 2026, 11:19:44 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for GEOVAX LABS, INC. (GOVX). Reported class ownership: 10%. Ownership change: +1.7%. Share change: -89%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

Treace Medical Concepts, Inc. (TMCI)

Schedule 13G/A Ownership 9.8% Filing-backed
CIK
000117266126002152
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
9.8%
Filed
15 May 2026, 11:19:26 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for Treace Medical Concepts, Inc. (TMCI). Reported class ownership: 9.8%. Ownership change: -0.14%. Share change: 0%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

GLUCOTRACK, INC. (GCTK)

Schedule 13G/A Ownership 5% Filing-backed
CIK
000117266126002148
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
5%
Filed
15 May 2026, 11:17:52 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for GLUCOTRACK, INC. (GCTK). Reported class ownership: 5%. Ownership change: -5%. Share change: +1%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Caligan Partners LP

SAB Biotherapeutics, Inc. (SABS)

Schedule 13G Ownership 10% Filing-backed
CIK
000172749226000011
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
10%
Filed
15 May 2026, 11:17:49 UTC
Period
31 Mar 2026

Caligan Partners LP filed Schedule 13G for SAB Biotherapeutics, Inc. (SABS). Reported class ownership: 10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
ARMISTICE CAPITAL, LLC CIK 0001601086 SQFT Presidio Property Trust, Inc. 75,718 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 HCWB HCW Biologics Inc. 353,680 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 GOVX GEOVAX LABS, INC. 291,155 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 TMCI Treace Medical Concepts, Inc. 6,364,000 9.8% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 GCTK GLUCOTRACK, INC. 102,115 5% SEC filing
Caligan Partners LP CIK 0001727492 SABS SAB Biotherapeutics, Inc. 7,967,207 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 TVTX TRAVERE THERAPEUTICS, INC. 4,897,417 5.3% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ESLA ESTRELLA IMMUNOPHARMA, INC. 4,280,375 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VRAX Virax Biolabs Group Limited 1,000,239 5% SEC filing
ROYAL BANK OF CANADA CIK 0001000275 LBRDP Liberty Broadband Corporation 331,996 4.6% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 EKSO Ekso Bionics Holdings, Inc. 187,151 5% SEC filing
ROYAL BANK OF CANADA CIK 0001000275 OBE OBSIDIAN ENERGY LTD 4,415,055 6.6% SEC filing
ROYAL BANK OF CANADA CIK 0001000275 WELPP Wisconsin Electric Power Company 19,103 7.4% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 DWTX DOGWOOD THERAPEUTICS, INC. 3,343,120 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VSEE VSee Health, Inc. 4,861,392 10% SEC filing
Solas Capital Management, LLC CIK 0001604867 MODD Modular Medical, Inc. 464,850 9.6% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CYCU Cycurion, Inc. 289,388 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CTOR Citius Oncology, Inc. 9,299,917 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CRIS Curis, Inc. 679,033 5% SEC filing
Chernett Jorey CIK 0002042077 WW WW INTERNATIONAL, INC. 507,356 5.1% SEC filing
PETTYJOHN, WOOD & WHITE, INC CIK 0001128213 BOTJ BANK OF THE JAMES FINANCIAL GROUP INC 224,259 4.9% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 CLDI CALIDI BIOTHERAPEUTICS, INC. 1,111,732 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BTAI BioXcel Therapeutics, Inc. 1,910,076 7% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BJDX Bluejay Diagnostics, Inc. 51,061 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VSTM Verastem, Inc. 4,592,000 5.2% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BDRX Biodexa Pharmaceuticals Plc 187,975 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 BCYC Bicycle Therapeutics plc 3,398,000 6.8% SEC filing
Cliffwater Corporate Lending Fund CIK 0001735964 CUSIP 06763A101 Barings Private Credit Corporation 42,041,303 29% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 AVNS AVANOS MEDICAL, INC. 2,000,000 4.3% SEC filing
Solas Capital Management, LLC CIK 0001604867 MAIA MAIA Biotechnology, Inc. 4,297,004 7.1% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 AUTL Autolus Therapeutics plc 15,800,000 5.9% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VVOS Vivos Therapeutics, Inc. 1,115,859 8.3% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ASTI Ascent Solar Technologies, Inc. 496,945 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ARTL ARTELO BIOSCIENCES, INC. 235,823 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VYGR Voyager Therapeutics, Inc. 3,500,000 5.9% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ARDS Aridis Pharmaceuticals, Inc. 5,096,251 11% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ALBT AVALON GLOBOCARE CORP. 890,521 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 WKSP WORKSPORT LTD. 611,096 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 AGIO AGIOS PHARMACEUTICALS, INC. 2,716,000 4.6% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 AEMD Aethlon Medical, Inc. 82,410 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 WLDS Wearable Devices Ltd. 230,752 8% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ADIL Adial Pharmaceuticals, Inc. 274,139 5% SEC filing
PARADIGM CAPITAL MANAGEMENT INC/NY CIK 0001037792 CRNC Cerence Inc. 2,507,276 5.6% SEC filing
Anson Funds Management LP CIK 0001491072 CJET Digital Currency X Technology Inc. 0 0% SEC filing
Solas Capital Management, LLC CIK 0001604867 FENC FENNEC PHARMACEUTICALS INC. 2,482,198 7.2% SEC filing
AQR CAPITAL MANAGEMENT LLC CIK 0001167557 RDAC Rising Dragon Acquisition Corp. 347,804 5.8% SEC filing
Caligan Partners LP CIK 0001727492 IRD Opus Genetics, Inc. 6,075,028 8.5% SEC filing
GMT CAPITAL CORP CIK 0001106191 CINT CI&T Inc 1,213,061 5.1% SEC filing
GMT CAPITAL CORP CIK 0001106191 CBRL Cracker Barrel Old Country Store, Inc. 1,590,700 7.1% SEC filing
Anson Funds Management LP CIK 0001491072 MBAV M3-BRIGADE ACQUISITION V CORP. 50,000 0.2% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .